380 likes | 498 Views
This program explores the comprehensive management of cancer-related cachexia, emphasizing the importance of understanding and addressing patient-reported end-of-life symptoms such as loss of appetite and weight loss. It covers the underlying mechanisms of cachexia, including the role of the ubiquitin-proteasome system, and presents evidence-based interventions. Key topics include parenteral nutrition, oral feeding strategies, and pharmacological treatments like megestrol acetate and anamorelin. The program also highlights new avenues of investigation aimed at enhancing body composition and overall quality of life for cancer patients.
E N D
Definition and Classification of Cancer CachexiaAn International Consensus
Effect on SurvivalOral Feeding for Malnourished Cancer Patients
Despite Improvements in Appetite, Quality of Life Is Not Always Improved
New Avenues of Investigation for Treatment of Cancer-related Cachexia
Antimyostatin TherapyImprovements in Body Weight and Survival
JAK Inhibition Associated With Weight Gain in Myelofibrosis Patients
Ghrelin Analogues Anamorelin for Treatment of Cancer Cachexia
Treatment With Anamorelin Improves Patient-reported Symptoms